PriceTargets.com logo

Klaviyo - KVYO Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $42.90
  • Forecasted Upside: 43.09%
  • Number of Analysts: 24
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 19 Buy Ratings
  • 1 Strong Buy Ratings
$29.98 As of 12/4/2025 04:59 PM ET
▲ +0.924 (3.18%)

This chart shows the closing price for KVYO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Klaviyo Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for KVYO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for KVYO

Analyst Price Target is $42.90
▲ +43.09% Upside Potential
This price target is based on 24 analysts offering 12 month price targets for Klaviyo in the last 3 months. The average price target is $42.90, with a high forecast of $60.00 and a low forecast of $30.00. The average price target represents a 43.09% upside from the last price of $29.98.

This chart shows the closing price for KVYO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 24 contributing investment analysts is to moderate buy stock in Klaviyo. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 15 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 15 buy ratings
  • 5 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 18 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 1 strong buy ratings
  • 19 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
11/4/2025
  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 1 strong buy ratings
  • 19 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2025Truist FinancialSet Target$45.00
11/17/2025William BlairReiterated RatingOutperform
11/11/2025MacquarieLower TargetNeutral ➝ Neutral$37.00 ➝ $30.00
11/10/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
11/7/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$48.00 ➝ $41.00
11/6/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$39.00 ➝ $40.00
11/6/2025Stifel NicolausLower TargetBuy ➝ Buy$42.00 ➝ $40.00
11/6/2025KeyCorpLower TargetOverweight ➝ Overweight$50.00 ➝ $45.00
11/6/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$50.00 ➝ $45.00
11/4/2025BenchmarkReiterated RatingBuy ➝ Buy
11/1/2025Weiss RatingsInitiated CoverageSell (D-)
10/29/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$48.00 ➝ $40.00
10/22/2025Jefferies Financial GroupUpgradeStrong-Buy
10/21/2025Jefferies Financial GroupInitiated CoverageBuy$32.00
9/30/2025Wells Fargo & CompanyInitiated CoverageOverweight ➝ Overweight$40.00
9/30/2025Wells Fargo & CompanyInitiated CoverageOverweight ➝ Overweight$40.00
9/26/2025Robert W. BairdLower TargetOutperform ➝ Outperform$44.00 ➝ $39.00
9/26/2025Piper SandlerReiterated RatingOverweight ➝ Overweight$55.00 ➝ $50.00
9/26/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$45.00
9/26/2025StephensLower TargetOverweight ➝ Overweight$45.00 ➝ $43.00
9/19/2025Morgan StanleyUpgradeEqual Weight ➝ Overweight$40.00 ➝ $50.00
8/8/2025Zacks ResearchUpgradeStrong Sell
8/7/2025CitigroupUpgradeNeutral ➝ Buy$40.00 ➝ $50.00
8/6/2025TD CowenBoost TargetBuy ➝ Buy$45.00 ➝ $46.00
8/6/2025Piper SandlerBoost TargetOverweight ➝ Overweight$40.00 ➝ $55.00
8/6/2025BenchmarkBoost TargetBuy ➝ Buy$44.00 ➝ $46.00
8/6/2025MacquarieReiterated RatingNeutral ➝ Neutral$37.00
7/15/2025Stifel NicolausLower TargetBuy ➝ Buy$45.00 ➝ $40.00
6/13/2025Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$32.00 ➝ $40.00
6/3/2025Cantor FitzgeraldUpgradeOverweight$48.00
5/7/2025ScotiabankSet TargetSector Perform ➝ Sector Perform$35.00
5/7/2025The Goldman Sachs GroupLower TargetBuy ➝ Buy$51.00 ➝ $44.00
5/7/2025BenchmarkBoost TargetBuy ➝ Buy$43.00 ➝ $44.00
5/7/2025BarclaysBoost TargetOverweight ➝ Overweight$35.00 ➝ $38.00
5/7/2025Piper SandlerBoost TargetOverweight ➝ Overweight$35.00 ➝ $40.00
5/7/2025Needham & Company LLCLower TargetBuy ➝ Buy$56.00 ➝ $45.00
5/5/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$26.00 ➝ $32.00
4/24/2025ScotiabankLower TargetSector Perform ➝ Sector Perform$45.00 ➝ $31.00
4/23/2025Piper SandlerLower TargetOverweight ➝ Overweight$53.00 ➝ $35.00
4/23/2025Robert W. BairdLower TargetOutperform ➝ Outperform$54.00 ➝ $37.00
4/22/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$45.00 ➝ $26.00
4/21/2025BarclaysLower TargetOverweight ➝ Overweight$51.00 ➝ $35.00
4/16/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$50.00 ➝ $34.00
4/16/2025Truist FinancialLower TargetBuy ➝ Buy$55.00 ➝ $40.00
4/15/2025MizuhoLower TargetOutperform ➝ Outperform$52.00 ➝ $40.00
3/19/2025StephensInitiated CoverageOverweight$43.00
2/20/2025BarclaysBoost TargetOverweight ➝ Overweight$47.00 ➝ $51.00
2/20/2025Stifel NicolausBoost TargetBuy ➝ Buy$45.00 ➝ $54.00
2/20/2025The Goldman Sachs GroupBoost TargetBuy ➝ Buy$45.00 ➝ $51.00
2/20/2025William BlairReiterated RatingOutperform
2/20/2025MizuhoBoost TargetOutperform ➝ Outperform$42.00 ➝ $52.00
2/20/2025Canaccord Genuity GroupBoost TargetBuy ➝ Buy$40.00 ➝ $50.00
2/20/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$47.00 ➝ $50.00
2/20/2025Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$47.00 ➝ $54.00
2/20/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$52.00 ➝ $54.00
2/20/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$48.00 ➝ $45.00
2/20/2025Piper SandlerBoost TargetOverweight ➝ Overweight$50.00 ➝ $53.00
2/20/2025Needham & Company LLCBoost TargetBuy ➝ Buy$46.00 ➝ $56.00
2/19/2025BenchmarkBoost TargetBuy ➝ Buy$40.00 ➝ $51.00
2/12/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$41.00 ➝ $48.00
2/11/2025CitigroupBoost TargetNeutral ➝ Neutral$39.00 ➝ $48.00
1/29/2025ScotiabankBoost TargetSector Perform ➝ Sector Perform$35.00 ➝ $45.00
1/13/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$38.00 ➝ $47.00
1/7/2025Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$37.00 ➝ $41.00
1/6/2025Piper SandlerBoost TargetOverweight ➝ Overweight$45.00 ➝ $50.00
12/23/2024Loop CapitalBoost TargetBuy ➝ Buy$45.00 ➝ $60.00
12/19/2024William BlairReiterated RatingOutperform
12/13/2024KeyCorpBoost TargetOverweight ➝ Overweight$42.00 ➝ $45.00
11/8/2024MacquarieReiterated RatingNeutral ➝ Neutral$36.00 ➝ $36.00
11/7/2024Needham & Company LLCBoost TargetBuy ➝ Buy$40.00 ➝ $46.00
11/7/2024Canaccord Genuity GroupBoost TargetBuy ➝ Buy$32.00 ➝ $40.00
11/7/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$42.00 ➝ $45.00
11/7/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$33.00 ➝ $47.00
11/7/2024BenchmarkLower TargetBuy ➝ Buy$42.00 ➝ $40.00
10/31/2024MacquarieInitiated CoverageNeutral$36.00
10/30/2024MacquarieUpgradeHold
10/24/2024BenchmarkReiterated RatingBuy ➝ Buy$42.00 ➝ $42.00
10/22/2024Stifel NicolausInitiated CoverageBuy$45.00
10/18/2024Wells Fargo & CompanyReiterated RatingBuy ➝ Buy
10/18/2024Piper SandlerBoost TargetOverweight ➝ Overweight$34.00 ➝ $45.00
10/16/2024Wells Fargo & CompanyInitiated CoverageEqual Weight$37.00
10/11/2024BarclaysBoost TargetOverweight ➝ Overweight$32.00 ➝ $41.00
10/10/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$35.00 ➝ $42.00
9/30/2024BenchmarkInitiated CoverageBuy$42.00
9/4/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00 ➝ $40.00
8/8/2024BarclaysBoost TargetOverweight ➝ Overweight$29.00 ➝ $32.00
8/8/2024Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$31.00 ➝ $33.00
8/8/2024Piper SandlerBoost TargetOverweight ➝ Overweight$30.00 ➝ $34.00
8/8/2024KeyCorpUpgradeSector Weight ➝ Overweight$33.00
7/12/2024Piper SandlerLower TargetOverweight ➝ Overweight$38.00 ➝ $30.00
6/12/2024BarclaysUpgradeEqual Weight ➝ Overweight$25.00 ➝ $29.00
5/17/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00
5/9/2024Canaccord Genuity GroupLower TargetBuy ➝ Buy$37.00 ➝ $32.00
5/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00
5/9/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$32.00 ➝ $25.00
5/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$31.00
5/9/2024Robert W. BairdLower TargetOutperform ➝ Outperform$40.00 ➝ $35.00
5/9/2024MizuhoLower TargetBuy ➝ Buy$40.00 ➝ $35.00
4/17/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$37.00 ➝ $32.00
4/16/2024Cantor FitzgeraldInitiated CoverageOverweight$31.00
4/2/2024ScotiabankInitiated CoverageSector Perform$30.00
3/21/2024KeyCorpInitiated CoverageSector Weight
3/20/2024FBN SecuritiesInitiated CoverageOutperform$35.00
2/28/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$38.00 ➝ $37.00
2/28/2024William BlairReiterated RatingOutperform
2/28/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$38.00
2/28/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00
2/5/2024The Goldman Sachs GroupUpgradeNeutral ➝ Buy$36.00
1/24/2024Piper SandlerReiterated RatingOverweight ➝ Overweight$38.00
1/12/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$37.00 ➝ $32.00
12/19/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00
12/8/2023Loop CapitalInitiated CoverageBuy$40.00
11/8/2023Piper SandlerReiterated RatingOverweight ➝ Overweight$38.00
10/16/2023Canaccord Genuity GroupInitiated CoverageBuy$37.00
10/16/2023Needham & Company LLCInitiated CoverageBuy$40.00
10/16/2023Morgan StanleyInitiated CoverageEqual Weight$38.00
10/16/2023Truist FinancialInitiated CoverageBuy$42.00
10/16/2023The Goldman Sachs GroupInitiated CoverageNeutral$36.00
10/16/2023Canaccord Genuity GroupInitiated CoverageBuy$37.00
10/16/2023MizuhoInitiated CoverageBuy$40.00
10/16/2023CitigroupInitiated CoverageNeutral$38.00
10/16/2023TD CowenInitiated CoverageOutperform$42.00
10/16/2023William BlairInitiated CoverageOutperform
10/16/2023BarclaysInitiated CoverageEqual Weight$37.00
10/16/2023Robert W. BairdInitiated CoverageOutperform$40.00
10/16/2023Piper SandlerInitiated CoverageOverweight$38.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.86 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 31 very positive mentions
  • 19 positive mentions
  • 11 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 30 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 8 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 13 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 47 very positive mentions
  • 24 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 38 very positive mentions
  • 23 positive mentions
  • 8 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 16 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 32 very positive mentions
  • 25 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 32 very positive mentions
  • 25 positive mentions
  • 7 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Klaviyo logo
Klaviyo, Inc., a technology company, provides a software-as-a-service platform in the United States, other Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers Klaviyo, a cloud-native platform for data store, segmentation engine, campaigns and flows, and messaging infrastructure. It also provides email to send personalized marketing emails, including drag-and-drop email templates to edit and customize pre-built templates; email campaigns and automations with smart send time features, generative artificial intelligence for subject line creation, A/B testing tools, and consumer list segmentation; short message services to send targeted marketing text messages to consumers, as well as built-in contact cards to ensure that texts does not appear as random numbers; and push, a personalized push notification to engage with consumer. In addition, the company offers other applications, such as reviews, which collect product reviews; and customer data platform that allows to manage, deploy, transform, and sync data. It serves its products to entrepreneurs, small and medium-sized businesses to mid-market businesses, and enterprises. The was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $29.98
Low: $29.03
High: $30.00

50 Day Range

MA: $27.05
Low: $23.68
High: $31.64

52 Week Range

Now: $29.98
Low: $23.44
High: $49.55

Volume

1,497,227 shs

Average Volume

2,846,972 shs

Market Capitalization

$9.05 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Klaviyo?

The following Wall Street analysts have issued reports on Klaviyo in the last year: Barclays PLC, Benchmark Co., Canaccord Genuity Group Inc., Cantor Fitzgerald, Citigroup Inc., Jefferies Financial Group Inc., KeyCorp, Loop Capital, Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Piper Sandler, Robert W. Baird, Scotiabank, Stephens, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, William Blair, and Zacks Research.
View the latest analyst ratings for KVYO.

What is the current price target for Klaviyo?

0 Wall Street analysts have set twelve-month price targets for Klaviyo in the last year. Their average twelve-month price target is $42.90, suggesting a possible upside of 43.1%. Loop Capital has the highest price target set, predicting KVYO will reach $60.00 in the next twelve months. Macquarie has the lowest price target set, forecasting a price of $30.00 for Klaviyo in the next year.
View the latest price targets for KVYO.

What is the current consensus analyst rating for Klaviyo?

Klaviyo currently has 1 sell rating, 3 hold ratings, 19 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for KVYO.

What other companies compete with Klaviyo?

Other companies that are similar to Klaviyo include CoreWeave, Wipro, MongoDB, Zoom Communications and Nebius Group. Learn More about companies similar to Klaviyo.

How do I contact Klaviyo's investor relations team?

The company's listed phone number is (617) 213-1788 and its investor relations email address is [email protected]. The official website for Klaviyo is www.klaviyo.com. Learn More about contacing Klaviyo investor relations.